(ABEV) Ambev - Ratings and Ratios
Beer, Soft Drinks, Malt, Alcoholic Beverages, Non-Alcoholic Products
ABEV EPS (Earnings per Share)
ABEV Revenue
Description: ABEV Ambev
Ambev SA ADR (NYSE:ABEV) is a leading beverage company operating in the production, distribution, and sale of various drinks, including beer, soft drinks, and other alcoholic and non-alcoholic beverages, across multiple regions such as Brazil, Central America, the Caribbean, and Canada. The companys diverse portfolio includes renowned brands like Skol, Brahma, Budweiser, and Guaraná Antarctica, among others.
From a strategic perspective, Ambevs strength lies in its extensive brand portfolio and widespread distribution network, which includes both third-party distributors and a direct distribution system. This allows the company to maintain a strong market presence across different geographies. To further analyze the companys performance, key performance indicators (KPIs) such as revenue growth, gross margin, and operating margin can be examined. For instance, a high gross margin could indicate the companys ability to maintain pricing power and efficient cost management.
Additionally, Ambevs financial health can be assessed by examining its debt-to-equity ratio, interest coverage ratio, and dividend yield. A reasonable debt-to-equity ratio and a high interest coverage ratio would suggest that the company is capable of managing its debt obligations. A stable dividend yield could attract income-seeking investors and indicate the companys commitment to returning value to shareholders.
To evaluate Ambevs competitive position and growth prospects, industry trends, market share, and the competitive landscape should be considered. The companys ability to adapt to changing consumer preferences, such as the shift towards healthier beverage options, and its capacity to innovate and expand its product portfolio, will be crucial in driving future growth.
From a valuation perspective, metrics such as the price-to-sales ratio, enterprise value-to-EBITDA, and dividend payout ratio can provide insights into the companys relative valuation and financial performance. Comparing these metrics to industry averages and peers can help determine whether Ambev is undervalued or overvalued.
ABEV Stock Overview
| Market Cap in USD | 34,862m |
| Sub-Industry | Brewers |
| IPO / Inception | 1997-03-05 |
ABEV Stock Ratings
| Growth Rating | 22.8% |
| Fundamental | 83.3% |
| Dividend Rating | 66.2% |
| Return 12m vs S&P 500 | -12.0% |
| Analyst Rating | 3.42 of 5 |
ABEV Dividends
| Dividend Yield 12m | 8.04% |
| Yield on Cost 5y | 10.17% |
| Annual Growth 5y | 5.66% |
| Payout Consistency | 81.5% |
| Payout Ratio | 56.2% |
ABEV Growth Ratios
| Growth Correlation 3m | -86.3% |
| Growth Correlation 12m | 58% |
| Growth Correlation 5y | -16.3% |
| CAGR 5y | 5.10% |
| CAGR/Max DD 5y | 0.11 |
| Sharpe Ratio 12m | -0.15 |
| Alpha | -0.70 |
| Beta | -0.099 |
| Volatility | 25.07% |
| Current Volume | 30672k |
| Average Volume 20d | 24908.7k |
| Stop Loss | 2.1 (-5.8%) |
| Signal | 0.53 |
Piotroski VR‑10 (Strict, 0-10) 8.0
| Net Income (14.75b TTM) > 0 and > 6% of Revenue (6% = 5.50b TTM) |
| FCFTA 0.15 (>2.0%) and ΔFCFTA 1.05pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 4.27% (prev 4.57%; Δ -0.30pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.18 (>3.0%) and CFO 26.28b > Net Income 14.75b (YES >=105%, WARN >=100%) |
| Net Debt (-13.25b) to EBITDA (27.03b) ratio: -0.49 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.11 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (15.74b) change vs 12m ago -0.45% (target <= -2.0% for YES) |
| Gross Margin 51.50% (prev 49.56%; Δ 1.94pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 64.23% (prev 56.40%; Δ 7.83pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 9.30 (EBITDA TTM 27.03b / Interest Expense TTM 2.36b) >= 6 (WARN >= 3) |
Altman Z'' 4.95
| (A) 0.03 = (Total Current Assets 40.79b - Total Current Liabilities 36.87b) / Total Assets 142.16b |
| (B) 0.03 = Retained Earnings (Balance) 4.32b / Total Assets 142.16b |
| (C) 0.15 = EBIT TTM 21.91b / Avg Total Assets 142.80b |
| (D) 3.46 = Book Value of Equity 169.41b / Total Liabilities 48.95b |
| Total Rating: 4.95 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 83.33
| 1. Piotroski 8.0pt = 3.0 |
| 2. FCF Yield 12.42% = 5.0 |
| 3. FCF Margin 23.61% = 5.90 |
| 4. Debt/Equity 0.03 = 2.50 |
| 5. Debt/Ebitda 0.12 = 2.49 |
| 6. ROIC - WACC 11.17% = 12.50 |
| 7. RoE 15.38% = 1.28 |
| 8. Rev. Trend 30.90% = 1.55 |
| 9. Rev. CAGR -0.89% = -0.15 |
| 10. EPS Trend -7.13% = -0.18 |
| 11. EPS CAGR -4.52% = -0.56 |
What is the price of ABEV shares?
Over the past week, the price has changed by +1.83%, over one month by -2.05%, over three months by -9.16% and over the past year by +3.54%.
Is Ambev a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of ABEV is around 2.22 USD . This means that ABEV is currently overvalued and has a potential downside of -0.45%.
Is ABEV a buy, sell or hold?
- Strong Buy: 2
- Buy: 2
- Hold: 7
- Sell: 1
- Strong Sell: 0
What are the forecasts/targets for the ABEV price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 2.8 | 26.5% |
| Analysts Target Price | 2.8 | 26.5% |
| ValueRay Target Price | 2.4 | 8.1% |
Last update: 2025-08-29 04:30
ABEV Fundamental Data Overview
CCE Cash And Equivalents = 17.52b BRL (Cash And Short Term Investments, last quarter)
P/E Trailing = 13.0
P/E Forward = 12.0773
P/S = 0.3801
P/B = 2.017
P/EG = 1.2586
Beta = 0.345
Revenue TTM = 91.72b BRL
EBIT TTM = 21.91b BRL
EBITDA TTM = 27.03b BRL
Long Term Debt = 2.06b BRL (from longTermDebt, last quarter)
Short Term Debt = 1.10b BRL (from shortTermDebt, last quarter)
Debt = 3.16b BRL (Calculated: Short Term 1.10b + Long Term 2.06b)
Net Debt = -13.25b BRL (from netDebt column, last quarter)
Enterprise Value = 174.31b BRL (188.67b + Debt 3.16b - CCE 17.52b)
Interest Coverage Ratio = 9.30 (Ebit TTM 21.91b / Interest Expense TTM 2.36b)
FCF Yield = 12.42% (FCF TTM 21.66b / Enterprise Value 174.31b)
FCF Margin = 23.61% (FCF TTM 21.66b / Revenue TTM 91.72b)
Net Margin = 16.08% (Net Income TTM 14.75b / Revenue TTM 91.72b)
Gross Margin = 51.50% ((Revenue TTM 91.72b - Cost of Revenue TTM 44.49b) / Revenue TTM)
Tobins Q-Ratio = 1.03 (Enterprise Value 174.31b / Book Value Of Equity 169.41b)
Interest Expense / Debt = 17.98% (Interest Expense 567.9m / Debt 3.16b)
Taxrate = 23.81% (from yearly Income Tax Expense: 4.64b / 19.49b)
NOPAT = 16.70b (EBIT 21.91b * (1 - 23.81%))
Current Ratio = 1.11 (Total Current Assets 40.79b / Total Current Liabilities 36.87b)
Debt / Equity = 0.03 (Debt 3.16b / last Quarter total Stockholder Equity 92.47b)
Debt / EBITDA = 0.12 (Net Debt -13.25b / EBITDA 27.03b)
Debt / FCF = 0.15 (Debt 3.16b / FCF TTM 21.66b)
Total Stockholder Equity = 95.95b (last 4 quarters mean)
RoA = 10.38% (Net Income 14.75b, Total Assets 142.16b )
RoE = 15.38% (Net Income TTM 14.75b / Total Stockholder Equity 95.95b)
RoCE = 22.36% (Ebit 21.91b / (Equity 95.95b + L.T.Debt 2.06b))
RoIC = 16.95% (NOPAT 16.70b / Invested Capital 98.51b)
WACC = 5.78% (E(188.67b)/V(191.83b) * Re(5.65%)) + (D(3.16b)/V(191.83b) * Rd(17.98%) * (1-Tc(0.24)))
Shares Correlation 5-Years: -100.0 | Cagr: -0.19%
Discount Rate = 5.65% (= CAPM, Blume Beta Adj.) -> floored to rf + ERP 8.05%
[DCF Debug] Terminal Value 79.64% ; FCFE base≈21.13b ; Y1≈23.30b ; Y5≈30.03b
Fair Price DCF = 33.49 (DCF Value 522.22b / Shares Outstanding 15.59b; 5y FCF grow 11.74% → 3.0% )
Revenue Correlation: 30.90 | Revenue CAGR: -0.89%
Rev Growth-of-Growth: 10.08
EPS Correlation: -7.13 | EPS CAGR: -4.52%
EPS Growth-of-Growth: 9.61
Additional Sources for ABEV Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle